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Abstract
Background: Ireland introduced a comprehensive workplace smoke-free legislation in March, 2004. Smoking-related
adverse birth outcomes have both health care and societal cost implications. The main aim of this study was to determine
the impact of the Irish smoke-free legislation on small-for-gestationa- age (SGA) births.
Methods and Findings: We developed a population-based birthweight (BW) percentile curve based on a recent study to
compute SGA (BW,5th percentile) and very SGA (vSGA - BW,3rd percentile) for each gestational week. Monthly births born
between January 1999 and December 2008 were analyzed linking with monthly maternal smoking rates from a large referral
maternity university hospital. We ran individual control and CUSUM charts, with bootstrap simulations, to pinpoint the
breakpoint for the impact of ban implementation ( = April 2004). Monthly SGA rates (%) before and after April 2004 was
considered pre and post ban period births, respectively. Autocorrelation was tested using Durbin Watson (DW) statistic.
Mixed models using a random intercept and a fixed effect were employed using SAS (v 9.2). A total of 588,997 singleton live-
births born between January 1999 and December 2008 were analyzed. vSGA and SGA monthly rates declined from an
average of 4.7% to 4.3% and from 6.9% to 6.6% before and after April 2004, respectively. No auto-correlation was detected
(DW=,2). Adjusted mixed models indicated a significant decline in both vSGA and SGA rates immediately after the ban
[(25.3%; 95% CI 25.43% to 25.17%, p,0.0001) and (20.45%; 95% CI: 20.7% to 20.19%, p,0.0007)], respectively.
Significant gradual effects continued post the ban periods for vSGA and SGA rates, namely, 20.6% (p,0.0001) and 20.02%
(p,0.0001), respectively.
Conclusions: A significant reduction in small-for-gestational birth rates both immediately and sustained over the post-ban
period, reinforces the mounting evidence of the positive health effect of a successful comprehensive smoke-free legislation
in a vulnerable population group as pregnant women.
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Introduction
Secondhand smoke (SHS) exposure is a Group I carcinogen and
there is no risk-free safe level of SHS exposure [1]. There is also
substantial evidence that both direct (firsthand) and maternal
exposure to SHS increase the risk of pregnancy complications
[2,3]. Maternal smoking during pregnancy is an important
modifiable risk factor and has both immediate and long-term
health consequences. For instance, mothers who smoked during
pregnancy have a two-fold increased risk of having low birth-
weight (LBW) babies compared to non-smoking mothers [4,5].
Many pregnant women continue to smoke, for example, one in
five pregnant women continues smoking in Ireland [6].
The population health impact of comprehensive smoke-free
policies is increasingly contributing to changing social norms of
a society. However, the effect of anti-smoking policies on pregnant
women is also of considerable interest both from a population
health and an economic perspective. To date, three studies have
documented that smoke-free legislations did have a positive impact
both on maternal smoking rates and on some adverse birth
outcomes, mainly preterm births and small-for-gestational age
births [6–8]. Each study has its own methodological limitations
and some strengths. However, it is imperative that similar studies
are performed across different population settings to reinforce such
growing evidence, which is limited at present.
Earlier we reported that maternal smoking rates in Ireland fell
by 12% one year after the Irish smoke-free legislation was
introduced in March 2004 [6]. The same study also reported
a 25% reduction in overall preterm birth risks after the smoke-free
legislation. A recent study in Scotland using retrospective cohort
design added further evidence suggesting that small-for-gestational
age (SGA) birth rates declined at least by 4.5% after the Scottish
smoke-free legislation of 2006 [7]. The present study builds on the
earlier Irish study and the most recent Scottish study to examine
a possible impact of the Irish smoke-free legislation on one of the
several smoking-related adverse birth outcomes, namely, SGA
birth rates over a 10-year period (January 1999 and December
2008) pre-post the ban, employing retrospective secondary
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analyses of individual-level data. Unlike the Scottish study [7], the
present study explores the effect both on late-stage of pregnancy
(measured by the month of delivery) and on early-stage of
pregnancy (measured by the month of conception). In addition,
the present study employs a newly developed population birth-
weight percentile reference curve for the general Irish population
to estimate SGA, unlike the Scottish study [7].
Methods
Ethics Statement
The Coombe Women and Infants University Hospital Ethics
Committee and the Dublin Institute of Technology (DIT) Ethics
Committee approved the study.
The National Perinatal Reporting System (NPRS) routinely
collects birth information from all maternity hospitals in Ireland.
Details on the NPRS can be accessed through the website (http://
www.esri.ie/health_information/nprs/). A concept proposal was
submitted to the ESRI (Economic and Social Research Institute)
in Ireland to get approval for accessing the dataset. Individual-
level data were acquired from the NPRS from January 1999 to
December 2008 (10 years) for all births in Ireland. Only singleton
live births were included in this analysis (n = 588,997).
Ireland does not have a birthweight (BW) percentile reference
curve. Therefore, a reference BW percentile for the Irish
population was developed to estimate SGA births, as discussed
below. No sample size estimation was performed, as the datasets
included all births across the whole of Ireland.
Calculation and Validation of SGA Estimates
SGA was estimated based on a recent Lancet study [9] (details
in Appendix S1), which derived a global reference foetal-weight
and BW percentile that is easily adapted to any local population.
We calculated mean BW at 40 weeks using singleton live-births
(n =,60,000) for year 2007 (mean BW=3,619 g) and the
standard deviation ( = 11.98%). Employing an easily adaptable
previously programmed Excel-based software, weight percentiles
for gestational age 24 weeks and beyond was calculated (Figure S1
and Table S1 in Appendix S2). BWs below the reference BW
against 3rd and 5th percentile for each gestational week thus
computed were considered very SGA (vSGA) and SGA for the
Irish population, respectively, similar to a recent study [10].
Average monthly SGA percentages were thus calculated for all
120 months (January 1999-December 2008).
For validation of the newly developed BW percentile curve, we
downloaded a previously validated tool- the GRAW (Gestation
Related Average Weight) Centile Calculator from the following
site: https://www.gestation.net/fetal_growth/graw/index.htm.
We adopted the same principle above of inputting the mean
BW at 40 weeks gestation ( = 3,619 g) for the year 2007 onto the
centile tool to plot another population-based BW percentile chart
(Table S2 in Appendix S2) both for comparison and for validation.
It is reassuring that 10th and 90th centile limits against each
gestational week $24 weeks for both these charts are broadly
similar (tables S1 &S2 in Appendix S2).
Month of Conception
The exact date of conception could not be calculated in the
present study, as the exact dates of births of babies were not
available to the study for ethical reasons. However, a close
approximation to the month of conception was feasible. We
calculated the month of conception subtracting gestational age (in
weeks) from the month of delivery for each singleton live-birth.
Next, we computed monthly SGA and vSGA rates (in percentages)
by month of conception. Because of fewer cases in the extremes of
month of conception, we excluded those live-births (totalling
,0.5%) of the total 588,997 singleton live-births, and thus
restricted to the conception period between April 1998 and
March 2008 (120 months in total). The monthly conception period
ranged from a maximum of 10 months (,40–41 gestational weeks)
to a minimum of 6 months (,24 gestational weeks) with 62 weeks
variations. A quick run of the frequency distribution of gestational
period of the study sample also revealed that .55% of the study
subjects fall within 40–41 weeks of gestation.
Outcome Measures
In this study, we proposed to use two main outcome measures –
first, monthly SGA and vSGA rates (%) by the month of birth
(January 1999-December 2008), and the second was monthly SGA
and vSGA rates (%) by the month of conception (April 1998–
March 2008). However, detailed outputs of the analyses pertaining
to all singleton live-births (n = 588,997) by month of delivery are
shown. Gestational age is primarily based on an early ultrasound
examination in Ireland (.95% of cases) [6].
Maternal Smoking Rates
The NPRS does not collect routine information on maternal
smoking rates. Corresponding monthly maternal smoking rates
were acquired from a tertiary large referral maternity hospital in
Dublin for the final model estimates. Detailed information on the
sources of maternal smoking data is available in our previous
publication [6]. In brief, mothers at the time of registration were
interviewed on a host of lifestyle, maternal and clinical character-
istics, including smoking status as a routine data collection
procedure which is inputted on an electronic clinical maternity
system, the Euroking K2 maternity system. Current smoking status
was derived from the self-reported affirmative responses to two
questions: i) ‘‘Did you ever smoked? Yes/No’’ and ‘‘Are you
currently smoking? Yes/No’’.
Smoking rates for full calendar years were available from 2000–
2008. First, individual-level maternal smoking rates were comput-
ed for all singleton live-births from the Coombe Women and
Infants University database from 2000–2008 (n=,60,000 single-
ton live births). Next, individual-level maternal smoking rates for
each SGA and vSGA births, as defined based on the newly derived
birthweight percentile curve, were estimated. Third, monthly
average smoking rates separately for SGA and vSGA babies were
computed for each calendar year (2000–2008). Finally, aggregate
monthly maternal smoking rates thus computed from 2000 to
2008 were linked with the NPRS dataset as against each individual
SGA and vSGA births by month of birth.
Because of the likelihood of non-comparability in methodologies
of both the datasets, sub-group analyses by smoking status were
not computed for the present study. 65% of the Coombe Women
and Infants University database comprises births from Dublin, and
not surprisingly administrative-specific overall maternal smoking
rates for all 30 administrative areas were highly skewed (appendix
S4). Therefore, computing administrative-specific maternal smok-
ing rates by SGA and vSGA for all 30 areas by each month may
potentially lead to reducing the validity and precision of such
estimates. However, mixed modelling techniques [as employed in
the present study] accounting for any underlying clustering effects
within and across these 30 administrative regions should indirectly
adjust for variations in maternal smoking rates within and across
these regions. Nonetheless, maternal smoking rates are self-
reported- so there is always a possibility of recall bias.
Smoking Ban and Small-For-Gestational Age Births
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Analyses
A total of 120 months were observed between January 1999 and
December 2008. First, we ran several individual control charts,
including CUSUM charts, separately for both observed monthly
SGA and vSGA rates (in percentages) by month of delivery to
pinpoint a possible breakpoint for the effect of the smoke-free
legislation using Taylor’s powerful change-point analysis tool.
Details of this tool are available on the website (http://www.
variation.com/cpa/tech/changepoint.html). Confidence intervals
at various levels were computed based on non-replacement
bootstrap simulations of 1000 samples to pinpoint the breakpoint.
Based on such computations, month ‘64’ corresponding to April
2004 was the breakpoint for both SGA and vSGA births when
significant changes occurred. Details of such computations are
explained in Appendix S3.
We ran similar individual control and CUSUM charts (Figures
S3 and S4 in Appendix S3) for monthly SGA and vSGA rates (%)
by month of conception (April 1998-March 2008) to pinpoint a possible
breakpoint for the effect of the smoke-free legislation using the
same change-point-analysis tool. Table S3 in Appendix S3, in line
with the explanations provided in Appendix S3 for tables S1 and
S2 indicate that point ‘64’ (here refers to month May 2003) is the
first most significant change point for monthly vSGA rates by
month of conception. On closer examination, point ‘64’
corresponds to a lag of 10 months duration from the month of
the Irish smoking ban ( = end of March 2004). Therefore, the
breakpoint identified earlier using individual month of delivery as
the unit of analysis, namely, April 2004, is consistent with using
individual month of conception as the unit of analysis. A similar
observation was noted for SGA rates by month of conception in
table S4 of Appendix S3. Taken together, April 2004 can be
confidently assigned as the breakpoint for the impact of the ban
implementation.
Thus, January 1999–April 2004 were considered pre-ban
period births, while May 2004–December 2008 was the post-
ban period in the present study.
Statistical Modelling
To start with, auto-correlation was assessed testing Durbin-
Watson statistic by modelling monthly aggregate-level data (Proc
AUTOREG) for both vSGA and SGA births, as well as factoring
three time-varying covariates into each model: overall secular
trend, gradual post-intervention trend (slope), and the immediate
intervention level (step change). No auto-correlation of first order
was detected (DW=,2.0). The estimates (intercepts and beta
coefficients) from these models were used to estimate expected
monthly vSGA and SGA rates by month of delivery, and to
compare expected monthly rates with observed monthly rates.
Preliminary analyses showed variations in SGA and vSGA
monthly rates within 30 administrative areas of Ireland indicating
a clustering effect. Therefore, individual-level data were modelled
using both a random intercept and a fixed effect model assuming
dependency within geographic locations (administrative areas). A
random intercept for SGA and vSGA implies that there is an
average SGA and vSGA rate in the population, but there is also
variability between geographic locations and within each geo-
graphic location. All such analyses were performed using Proc
MIXED of SAS v9.2.
The final mixed model estimates were adjusted for several socio-
demographic and physiological characteristics available to the
study [sex of the child, maternal age, maternal and paternal
occupational status, marital status, antenatal care, parity, maternal
smoking rates], and the clustering effect of maternal residence
within the 30 administrative areas. Time was included into the
model as a continuous variable from month 1 in January 1999 to
month 120 in December 2008 to capture overall secular trends in
both SGA and vSGA rates over time. An indicator variable was
used to define the smoking ban, with a value of zero given to the
months before ban implementation and a value of one given for
the month after the ban was implemented (April, 2004) and all
following months to estimate the post-intervention level (step
change). Finally, values of one were given for the breakpoint
( =April 2004) – one month of ban implementation and the
subsequent months up to 1, 3, 6, or 12 months post-ban with all
other months before the breakpoint denoted by a value of zero for
estimating the gradual post-intervention trend (slope). Following
model convergence, the goodness-of-fit of models was assessed
using the Akaike Information Criterion (AIC) – the smaller the
AIC better the model. The immediate intervention level (step
change) and the gradual post-intervention trend (slope) both in
vSGA and SGA monthly rates were computed, including robust
standard error estimates.
Furthermore, a similar statistical modelling was employed to
examine the impact of the ban implementation on SGA and vSGA
monthly rates (in percentages) by the month of conception (details
not shown) – April 1998- March 2008 (coded as ‘1’ =April 1998 to
‘120’ =March 2008).
Finally, to delineate the effects of premature babies, all singleton
live-births known to be born premature (defined as births ,37
completed gestational weeks) were excluded (totalling,8%) to run
a similar statistical modelling for adjusted estimates of immediate
post-intervention level (step change) and a gradual post-interven-
tion trend (slope) in both monthly SGA and vSGA rates.
Results
Figure 1 shows yearly maternal smoking rates from 2000 to
2008 available from the Coombe Women and Infants University
Hospital. Figure 1 also shows that yearly smoking rates among
mothers who had SGA and vSGA births are relatively higher
compared to yearly overall maternal rates, which remain high in
Ireland.
Figure 2 shows both the observed and the modelled (expected)
estimates of vSGA and SGA monthly rates (in percentages) by
month of delivery between January 1999 and December 2008
indicating a step change during month 64 corresponding to April
2004. The observed monthly vSGA rates before the ban were
4.7% on average which fell to an average of 4.3% in the post-ban
period (row 64 in Table S1 of Appendix S3). A similar pattern was
observed for SGA monthly rates (from an average of 6.9% to
6.6%, respectively, as shown in row 64 in Table S2 of Appendix
S3).
Table 1 details the immediate post-intervention level (step
change) and the gradual post-intervention trend (slope) estimates
across different parameters of analyses following adjusted mixed
modelling. The adjusted estimates indicate that vSGA rates
showed a much greater immediate effect compared to SGA rates
- a decline of 25.3% [95%CI: 25.43% to 25.17%; (p,0.0001)]
compared to 20.45% [95%CI: 20.70% to 20.19%; (p = 0.0007)]
decline in SGA rates. Gradual post-intervention effects in both
vSGA and SGA rates were smaller- a monthly decline of 20.6%
[SE 0.002; (p,0.0001)] and 20.02% [SE 0.004; (p,0.0001) in
respective vSGA and SGA rates after the ban.
Table 1 also shows that a significant 24.5% immediate post-
intervention decline was observed in monthly vSGA rates when
analyzed by the month of conception. In summary, immediate and
gradual post-intervention effects were observed irrespective of
Smoking Ban and Small-For-Gestational Age Births
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modelling by the month of delivery or by the month of conception,
and even excluding premature births.
Discussion
This study quantifies the impact of a comprehensive smoke-free
legislation on a potentially preventable adverse birth outcome,
namely, small-for-gestational age births derived from a newly
developed population-based birthweight percentile reference
curve. The study findings indicate a significant decline of
25.3% in vSGA rates in Ireland immediately after the ban,
which is in agreement with a recent Scottish study [7]. Significant
gradual post-intervention trends were also observed, namely,
a monthly decline of 20.6% in vSGA rates sustained throughout
the post-ban periods, and of similar direction but of smaller
magnitude for monthly SGA rates (20.02%). Such observations
add to the body of evidence indicating the positive health impact
of comprehensive smoke-free legislations both in Ireland and in
comparable populations elsewhere [12,13]. The fact that greater
effects were observed in vSGA babies than in SGA babies
underscores both the physiological importance and the vulnera-
bility of babies considered to be the ‘smallest’ biologically and also
having the largest intra-uterine growth restriction in absolute
terms. Furthermore, an estimated immediate post-intervention fall
of 24.5% when analyzed by the month of conception indirectly
Figure 1. Yearly smoking rates (%) in pregnant women and in mothers who gave birth to low weight (LBW), preterm, small-for-
gestational age (SGA) and very (vSGA) babies from 2000 to 2008.
doi:10.1371/journal.pone.0057441.g001
Figure 2. Monthly observed and modelled (expected) small-for-gestational age (SGA) and very SGA (vSGA) rates in Ireland by
month of delivery, January 1999-December 2008 [the bar indicates month 64 ( =April 2004).
doi:10.1371/journal.pone.0057441.g002
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suggests that the smoking ban had a similar effect during the early-
stage of pregnancy.
Despite methodological challenges, the present study has several
strengths. First, the development of an Irish population-based
birthweight percentile reference curve for estimating SGA rates in
Ireland is novel and timely. The Scottish study [7] despite the
availability of a Scottish BW percentile reference curve [14] did
not utilize such curves for SGA computations. Second, the present
study validated the newly developed BW percentile curve using
a previously validated GRAW (Gestation Related Average
Weight) Centile Calculator [11]. Third, detailed analyses were
performed to pinpoint and to delineate the most significant visible
breakpoint rather than arbitrarily selecting the actual month of the
Irish smoking ban implementation, utilizing a powerful change-
point analysis tool across different units of analyses: individual
month of births vs. individual month of conception. Fourth,
employing a robust mixed modelling technique accounted for both
clustering effects within and between geographic locations and the
underlying secular trends before and after the smoke-free
legislation, thus clearly taking advantage of individual-level data
available for a longer period. Fifth, examining such effects both on
early-stage of pregnancy (analysis by month of conception) and on
late-stage of pregnancy (analysis by month of delivery), as well as
exploring only ‘term’ singleton live-births - all providing similar
estimates is reassuring. Finally, a large nationally representative
sample of more than half a million singleton live-births clearly
added statistical power to the study findings, thereby also avoiding
selection bias.
The present study, however, has inherent methodological
limitations. The cross-sectional retrospective study design limits
causal inferences. Unmeasured/unidentified factors are more
likely to introduce residual confounding. The linkage of maternal
smoking rates available from a single large referral centre with
a national perinatal reporting system data raises issues of external
validity and generalization of maternal smoking rates. However,
various sources of maternal smoking statistics in Ireland are
consistent with the data utilized in this study [15–16]. In addition,
the computations of monthly maternal smoking rates separately
for SGA and vSGA births may have accounted in part for any
underlying biases in population mean estimates, thus minimising
ecologic fallacies. Although recall bias is a possibility using self-
reported maternal smoking rates but evidence suggests that self-
reported smoking habits (including SHS exposure) by pregnant
women is in good agreement with objective measurements of
cigarette exposure [17] or may be an underestimate [18].
The observed declines are biologically plausible. A recent
Scottish study showed an immediate effect [7], more precisely, the
same study showed an effect 3 months before the implementation
of the Scottish ban. The present study captures both early and late
effects of SHS exposure levels on pregnancy complications. A
causal relationship is supported by a recent randomized in-
tervention where infants born to mothers in the intervention group
with reduced SHS exposure had a significant lower risk of adverse
birth outcomes [19]. Active maternal smoking has detrimental
effects on placental architecture, placental function, and early and
late foetal growth, predisposing to a range of adverse birth
outcomes [20–21]. Evidence also suggests that it is during the third
trimester of pregnancy when smoking restricts foetal growth
regardless of the previous smoking history [22–23]. Although
difficult to delineate accurately the possible health effects across
different periods of gestation, a similar positive health effect of the
ban observed on SGA rates when analyzed by the month of
conception would also indirectly capture any underlying effects on
the early-stage of pregnancy. A recent study in the US also
determined how a population-level intervention (here a smoke-free
policy) could translate into improvements at the individual level
through reductions in preterm birth risks [8]. Nevertheless, it is
always difficult to extrapolate changes in smoking behaviour
among the general population to pregnant women [24], but the
marginal fall in maternal smoking behaviour that was observed
earlier in Ireland is also plausible.6 In addition, completely smoke-
free homes are increasing in Ireland [25–26]. No significant
changing obstetric practices were reported in Ireland coinciding
with the ban implementation. However, the general observations
in recent years of increasing elective Caesarean rates or a shift to
higher average age of pregnant women, as well as a rise in obese
mothers giving births may have influenced the study findings but
are more likely to bias toward the null [24].
In conclusion, positive health effects after the introduction of the
Irish smoke-free legislation are mounting [12,27]. The growing
evidence in support of the positive population health gains of
smoke-free policies for a vulnerable population, such as pregnant
Table 1.Mixed model estimates* of immediate post-intervention level (step changes) and gradual post-intervention trends (slope)
for monthly Small-for-gestational (SGA) and very SGA (vSGA) rates in Ireland, January 1999-December 2008.
Outcome measures Immediate Effects (step change) Gradual Effects (slope change)
Coefficients*100 [SE] ‘p’ value Coefficients*100 [SE] ‘p’ value
Month of delivery (n =588,997)
vSGA 25.3 [0.06] ,0.0001 20.6 [0.002] ,0.0001
SGA 20.45 [0.13] 0.0007 20.02 [0.004] ,0.0001
Excluding premature births (n =541,039)
vSGA 24.5 [0.064] ,0.0001 20.58 [0.002] ,0.0001
SGA 20.39 [0.13] 0.003 20.018 [0.004] ,0.0001
**Excluding mat smoking (n =588,997)
vSGA 22.7 [0.11] 0.01 20.01 [0.003] 0.11
SGA 20.31 [0.13] 0.02 20.01 [0.004] 0.0005
*Adjusted for maternal smoking (not for **); maternal age; parity; sex of the baby; marital status; antenatal care; mother’s occupation; father’s occupation; secular trend,
and clustering effect with and between 30 administrative regions.
SE = Standard Error.
doi:10.1371/journal.pone.0057441.t001
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women on pregnancy complications, is both encouraging and
crucial [24]. In addition to immediate gains, smoking-related
adverse birth outcomes are preventable considering the long-term
health care and societal cost implications. Future studies of similar
nature should also address the methodological limitations akin to
cross-sectional ecologic designs or retrospective secondary data
analytical study designs. Details on personalized information on
changing maternal obesity patterns or on maternal smoking
exposure levels across different socio-economic groups, as well as
changing obstetric practices may provide additional insights into
future studies.
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